MX2021013111A - Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio. - Google Patents
Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio.Info
- Publication number
- MX2021013111A MX2021013111A MX2021013111A MX2021013111A MX2021013111A MX 2021013111 A MX2021013111 A MX 2021013111A MX 2021013111 A MX2021013111 A MX 2021013111A MX 2021013111 A MX2021013111 A MX 2021013111A MX 2021013111 A MX2021013111 A MX 2021013111A
- Authority
- MX
- Mexico
- Prior art keywords
- respiratory tract
- prevention
- treatment
- tract infection
- subunit vaccine
- Prior art date
Links
- 206010057190 Respiratory tract infections Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 229940031626 subunit vaccine Drugs 0.000 title 1
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 abstract 1
- 241000351643 Metapneumovirus Species 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175413 | 2019-05-20 | ||
| PCT/EP2020/063973 WO2020234300A1 (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021013111A true MX2021013111A (es) | 2021-11-17 |
Family
ID=66685352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021013111A MX2021013111A (es) | 2019-05-20 | 2020-05-19 | Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20220185847A1 (ko) |
| EP (1) | EP3972639A1 (ko) |
| JP (1) | JP2022533318A (ko) |
| KR (1) | KR20220010478A (ko) |
| CN (1) | CN114127101A (ko) |
| AU (1) | AU2020277661A1 (ko) |
| CA (1) | CA3138064A1 (ko) |
| CL (1) | CL2021002819A1 (ko) |
| CO (1) | CO2021014694A2 (ko) |
| EC (1) | ECSP21079178A (ko) |
| GB (1) | GB2598494A (ko) |
| IL (1) | IL287099A (ko) |
| MX (1) | MX2021013111A (ko) |
| PE (1) | PE20220400A1 (ko) |
| SG (1) | SG11202110646PA (ko) |
| WO (1) | WO2020234300A1 (ko) |
| ZA (1) | ZA202106883B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021205022A1 (en) | 2020-04-09 | 2021-10-14 | Valneva Austria Gmbh | Improved methods of producing a lipidated protein |
| CA3195015A1 (en) | 2020-10-09 | 2022-04-14 | Jason MCLELLAN | Prefusion-stabilized hmpv f proteins |
| EP4243865A1 (en) | 2020-11-13 | 2023-09-20 | Icosavax, Inc. | Protein-based nanoparticle vaccine for metapneumovirus |
| AU2022255923A1 (en) | 2021-04-09 | 2023-08-31 | Valneva Se | Human metapneumo virus vaccine |
| WO2023110618A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2194761C (en) | 1994-07-15 | 2006-12-19 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| KR100799788B1 (ko) | 2000-06-08 | 2008-01-31 | 인터셀 아게 | 면역촉진성 올리고디옥시뉴클레오티드 |
| EP1309345A2 (en) | 2000-08-17 | 2003-05-14 | Cistem Biotechnologies GmbH | Cathelicidins as vaccine adjuvants |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| CA2447793A1 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Immunostimulatory oligodeoxynucleic molecules |
| US20050250716A1 (en) | 2001-12-07 | 2005-11-10 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
| US7704720B2 (en) * | 2003-04-25 | 2010-04-27 | Medimmune, Llc | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| HUE037325T2 (hu) | 2011-12-06 | 2018-08-28 | Valneva Austria Gmbh | Alumíniumvegyületek gyógyszerekben és vakcinákban történõ alkalmazásra |
| WO2016103238A1 (en) | 2014-12-24 | 2016-06-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant metapneumovirus f proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
-
2020
- 2020-05-19 KR KR1020217034461A patent/KR20220010478A/ko unknown
- 2020-05-19 WO PCT/EP2020/063973 patent/WO2020234300A1/en active Application Filing
- 2020-05-19 SG SG11202110646PA patent/SG11202110646PA/en unknown
- 2020-05-19 CA CA3138064A patent/CA3138064A1/en active Pending
- 2020-05-19 PE PE2021001766A patent/PE20220400A1/es unknown
- 2020-05-19 MX MX2021013111A patent/MX2021013111A/es unknown
- 2020-05-19 AU AU2020277661A patent/AU2020277661A1/en active Pending
- 2020-05-19 JP JP2021564088A patent/JP2022533318A/ja active Pending
- 2020-05-19 CN CN202080030901.9A patent/CN114127101A/zh active Pending
- 2020-05-19 GB GB2114836.6A patent/GB2598494A/en active Pending
- 2020-05-19 US US17/606,811 patent/US20220185847A1/en active Pending
- 2020-05-19 EP EP20726137.1A patent/EP3972639A1/en active Pending
-
2021
- 2021-09-17 ZA ZA2021/06883A patent/ZA202106883B/en unknown
- 2021-10-07 IL IL287099A patent/IL287099A/en unknown
- 2021-10-25 EC ECSENADI202179178A patent/ECSP21079178A/es unknown
- 2021-10-26 CL CL2021002819A patent/CL2021002819A1/es unknown
- 2021-10-29 CO CONC2021/0014694A patent/CO2021014694A2/es unknown
-
2023
- 2023-10-24 US US18/493,004 patent/US20240067681A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CL2021002819A1 (es) | 2022-07-08 |
| ECSP21079178A (es) | 2021-11-30 |
| ZA202106883B (en) | 2022-07-27 |
| PE20220400A1 (es) | 2022-03-22 |
| AU2020277661A1 (en) | 2021-10-21 |
| WO2020234300A1 (en) | 2020-11-26 |
| US20220185847A1 (en) | 2022-06-16 |
| CO2021014694A2 (es) | 2022-01-17 |
| GB2598494A (en) | 2022-03-02 |
| JP2022533318A (ja) | 2022-07-22 |
| US20240067681A1 (en) | 2024-02-29 |
| KR20220010478A (ko) | 2022-01-25 |
| EP3972639A1 (en) | 2022-03-30 |
| IL287099A (en) | 2021-12-01 |
| CA3138064A1 (en) | 2020-11-26 |
| GB202114836D0 (en) | 2021-12-01 |
| SG11202110646PA (en) | 2021-10-28 |
| CN114127101A (zh) | 2022-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021013111A (es) | Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio. | |
| MX2020010941A (es) | Moleculas y composiciones novedosas de arn de vsr para vacunacion. | |
| EA201070794A1 (ru) | Рекомбинантные антигены rsv | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| CY1117673T1 (el) | Ανασυνδυασμενα αντιγονα rsv | |
| MX2019008564A (es) | Composiciones inmunogenicas para su uso en vacunas neumococicas. | |
| CY1117757T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
| BR112018009032A2 (pt) | vetor viral de arenavírus infeccioso, composição farmacêutica, composição imunogênica, vacina, método para o tratamento ou a prevenção de infecção pelo vírus da hepatite b em um paciente, uso de um vetor viral, ácido nucleico isolado, vetor viral de arenavírus infeccioso deficiente em replicação e método para sua geração | |
| CR20210306A (es) | Proteínas f de prefusión del vrs estabilizadas | |
| MD3439672T2 (ro) | Proteine F RVS de pre-fuziune solubile stabilizate pentru utilizare în profilixia infecţiilor cu RSV | |
| MX2018013782A (es) | Antigenos y vacunas dirigidos contra enterovirus humanos. | |
| PH12018502332A1 (en) | Stabilized pre-fusion rsv f proteins | |
| WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| PH12016502039A1 (en) | Potent and selective inhibitors of hepatitis c virus | |
| MX2023000024A (es) | Combinación vacunal contra la infección por el virus respiratorio sincicial. | |
| MY170991A (en) | Dosing regimens of celgosivir for the treatment of dengue | |
| IN2014DN08927A (ko) | ||
| MX2021001228A (es) | Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria. | |
| MX2022008036A (es) | Nuevo uso de formulacion inmunogenica bcg que expresa una proteina de virus respiratorio sincicial contra hmpv. | |
| MX2023005221A (es) | Composiciones inmunogenicas para uso en vacunas neumococicas. | |
| WO2022214678A3 (en) | Human metapneumo virus vaccine | |
| HUP1800178A1 (hu) | Eljárás bõrfertõzések kezelésére és megelõzésére alkalmas külsõleges gyógyhatású készítmények elõállítására | |
| PL413055A1 (pl) | Zastosowanie modyfikowanej anionowo polialliloaminy jako leku do blokowania replikacji ludzkiego rinowirusa (HRV) oraz profilaktyki i leczenia wywołanych nim infekcji dróg oddechowych | |
| WO2011066006A3 (en) | Methods for treating aids |